Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Alan Scott Enterprises Limited Appoints Mr. Shailesh Haribhakti as Group Chief Mentor Business
  • Mentors from Google, Oracle, Infosys, Flipkart, and Other Global Companies Guide Students at Red & White Skill Education Education
  • Global movement Veganuary launches in India Lifestyle
  • Realtor Nitish Agarwal ties the knot with friend-turned-soulmate Kalpana Tharwani Lifestyle
  • Media Entrepreneur Waahiid Ali Khan’s horse Basharat wins Malaysia Cup Race Press Release
  • B.A.G. Convergence Limited IPO Opens on September 30, 2025 Business
  • Sandeep Marwah Honoured with Prestigious Literature Award in Sydney Lifestyle
  • Unveiling Exclusive Beauty Bliss: Join Shades Of Blackk Spalon’s Elite Membership Experience Business

Eyestem files for IND approval for its product to treat geographic atrophy, the largest cause of incurable blindness in the world for people over 50

Posted on June 5, 2023 By

Bengaluru (Karnataka) [India], June 5: Dry age-related macular degeneration (dry AMD) is the largest cause of incurable blindness in the world for patients over 50 years. 170 million people suffer from this disease around the world, 25 million of which are in India. These numbers will, unfortunately, increase in the coming decades as our population ages. The more severe version of dry AMD is geographic atrophy, and no therapy is available to arrest or reverse this loss of vision.

Eyestem Research today announced the submission of an Investigational New Drug (IND) application to the Central Drugs Standards Control Organization, India (CDSCO) to begin first-in-human trials of Eyecyte-RPE™for subjects with medium- and late-stage geographic atrophy, secondary to dry AMD.

Dr. Rajani Battu, Chief Medical Officer of Eyestem Research, said, “We are excited to start human trials for Eyecyte-RPE™. Dry AMD is a huge disease burden, and this therapy has the potential to make a meaningful difference in our patient’s lives.”

Dr. Jogin Desai, Chief Executive Officer of Eyestem Research, said, “Most cell and gene therapy products under development in the West are estimated to cost over US$ 200,000.Our vision is to democratize access to such treatments at a fraction of these costs and begin disruption of the current status quo with our Eyecyte-RPE™ product.”

Eyestem Research is a deep science company incubated at the Centre for Cellular and Molecular Platforms, Bangalore, and supported by DBT-BIRAC as well as prestigious Indian and global healthcare investors. The IND submission for Eyecyte-RPE™is supported by robust GLP toxicology data from Dabur Research Foundation in India and excellent efficacy/safety data in animal models at Oregon Health and Science University. Validation of the injection technique and dose-finding studies were done in advanced animal models at the Singapore Eye Research Institute.

About Eyecyte-RPE™

Eyecyte-RPE™ is a patented suspension of iPSC-derived fate-committed retinal pigment epithelium cells, which are highly potent, safe, and efficacious in in-vitro and in-vivo studies. The cells are derived from induced pluripotent stem cells, are allogeneic in nature, and can be stored for long periods of time.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Health Tags:Healthcare

Post navigation

Previous Post: Kindness Practice Foundation conducted free cancer awareness camp at Mumbai
Next Post: Save Earth Mission’s Global Community Rallies For World Environment Day

Related Posts

  • SVayurved Unveils Digital Gateway to Diabetes Reversal and Empowers Healthcare Professionals with Holistic Training Health
  • Indian Association of Dermatologists, Venereologists, and Leprologists recommends a good skincare routine on World Skin Health Day English
  • On the eve of World Cancer Day, Global Healthcare Advisor Vijay Dhawangale shares his views on awareness in the fight against cancer Health
  • Child Not Improving in Therapy? Why a Full Child Psychological Assessment Should Come First, as Indian-Origin Parents Abroad Seek Online Help Health
  • Groundbreaking Mental Health Platform SayHey App Launches, Offering Anonymous Support and Community Connection Health
  • Best Health Experts in India Advice on Gynecologic & Blood Cancers Health

Recent Posts

  • Pan IIT Alumni India Welcomes PM Modi’s Visit to IIT Kharagpur for Platinum Jubilee Celebrations
  • ‘Plast Pack 2026’ Begins with Bhoomi Pujan; Mega Plastic Industry Expo to Commence on November 27
  • The Ambiente Brings Luxury Handmade Rugs and Carpets Online to Homes Across India
  • ‘Mere Mahavir 3.1 – Mahavir Nirvana Katha’ Concludes on a Grand Spiritual Note at Bharat Mandapam
  • HydraSure’s Gen Z Team Turns GTA VI Launch Day Into a Giveaway – Planned and Live in 24 Hours

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Hanuman Emergency Health Care Celebrates Thriving Third Anniversary, Saving Lives with Uncompromising Commitment Business
  • IMS Ghaziabad (University Courses Campus) Organizes Faculty Development Programme on ‘Teaching Creatively’ to Promote Pedagogical Innovation Education
  • Maxzone Clothing: A Meteoric Rise to the Top as India’s Fastest-Growing T-Shirt Brand in 2023 Business
  • Pratitee Bordoloi: Indian Chess Prodigy in the making!! Sports
  • Rikhav Securities Closes FY25 with INR 24 Cr Consolidated Net Profit Business
  • OBCs’ Empowerment: ‘The OBCs Uprising’ Garners Tremendous Response; Narahari’s Shakari-Vikramaditya’ Also Forthcoming Lifestyle
  • Author Vijayalatha’s literary work inspires people to reinvent   Lifestyle
  • eCampus Edu reports regional trends among online learners in India; notes rise in second degrees and ROI focus Education

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme